Alexandre Akoulitchev
Alexandre Akoulitchev serves as the chief scientific officer at Oxford Biodynamics (OBD), where he plays a pivotal role in advancing research on chronic fatigue syndrome. He was instrumental in the development of an epigenetic-based blood test for ME/CFS, which is expected to significantly improve the accuracy of diagnoses and patient management.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Alexandre Akoulitchev is the chief scientific officer at OBD, which funded and co-authored the research.
7